Camlin Fine Sciences Ltd

Camlin Fine Sciences Ltd Share Price Today: Live Updates & Key Insights

Get insights on Camlin Fine Sciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Camlin Fine Sciences Ltd Share Price Chart

Camlin Fine Sciences Ltd Fundamentals

Traded Volume: 3,21,489

Market Cap(Cr): 2,896

Avg Traded Price 155.25

1 Year return 32.31%

Upper Circuit 158.9

Lower Circuit 153.4

P/E TTM -99.00

P/B Ratio -2.00

Traded Value(Cr) 495.32

EPS TTM -1.554

Book value -1.554

Dividend 0.00%

Camlin Fine Sciences Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Camlin Fine Sciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Camlin Fine Sciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -9.72%

1M -15.94%

3M -26.53%

1Y +32.31%

YTD +14.35%

Camlin Fine Sciences Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Camlin Fine Sciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 4.28L

Day Before Yesterday 5.97L

1W Avg 5.05L

1M Avg 6.32L

3M Avg 5.28L

Camlin Fine Sciences Ltd Technical Details

Camlin Fine Sciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 152

Support 2 150

Support 3 147

Pivot Point : 155

Resistance 1 158

Resistance 2 161

Resistance 3 163

Camlin Fine Sciences Ltd Corporate Actions

Camlin Fine Sciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Camlin Fine Sciences Ltd’s capital allocation strategies.

All

Ex-Date 08-Jan-2025 Type R Description /share@5:41% Record Date 08-Jan-2025 Ratio 5:41

Ex-Date 28-Jul-2016 Type D Description 0.45/share@45.00% Record Date - Ratio 45.00

Ex-Date 27-Jul-2015 Type D Description 0.45/share@45.00% Record Date - Ratio 45.00

Ex-Date 04-Sep-2014 Type S Description share@1:2.00 Record Date 05-Sep-2014 Ratio 1:2.00

Ex-Date 24-Jul-2014 Type D Description 0.70/share@35.00% Record Date - Ratio 35.00

Ex-Date 01-Aug-2013 Type D Description 0.60/share@30.00% Record Date - Ratio 30.00

Ex-Date 23-Jul-2012 Type D Description 0.50/share@25.00% Record Date - Ratio 25.00

Ex-Date 15-Feb-2012 Type S Description share@1:5.00 Record Date 17-Feb-2012 Ratio 1:5.00

Ex-Date 20-Jul-2011 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00

Ex-Date 30-Jul-2010 Type R Description /share@3:5% Record Date 02-Aug-2010 Ratio 3:5

Ex-Date 22-Jun-2010 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00

Ex-Date 12-Aug-2009 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00

Ex-Date 30-Jul-2008 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00

Dividends

Announcement Date 28-Jul-2016 Ex Dividend Date 28-Jul-2016 Dividend(%) 45

Announcement Date 27-Jul-2015 Ex Dividend Date 27-Jul-2015 Dividend(%) 45

Announcement Date 24-Jul-2014 Ex Dividend Date 24-Jul-2014 Dividend(%) 35

Announcement Date 01-Aug-2013 Ex Dividend Date 01-Aug-2013 Dividend(%) 30

Announcement Date 23-Jul-2012 Ex Dividend Date 23-Jul-2012 Dividend(%) 25

Announcement Date 20-Jul-2011 Ex Dividend Date 20-Jul-2011 Dividend(%) 20

Announcement Date 22-Jun-2010 Ex Dividend Date 22-Jun-2010 Dividend(%) 20

Announcement Date 12-Aug-2009 Ex Dividend Date 12-Aug-2009 Dividend(%) 15

Announcement Date 30-Jul-2008 Ex Dividend Date 30-Jul-2008 Dividend(%) 10

Bonus

No Bonus has been declared by CAMLINFINE

Splits

Record Date 05-Sep-2014 Split Date 04-Sep-2014 Face Value (Before/After) 2.00/1.00

Record Date 17-Feb-2012 Split Date 15-Feb-2012 Face Value (Before/After) 10.00/2.00

Others

Ex-Rights Date 08-Jan-2025 Premium(Rs.) 109.00 Ratio 5:41

Ex-Rights Date 30-Jul-2010 Premium(Rs.) 5.75 Ratio 3:5

Camlin Fine Sciences Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Camlin Fine Sciences Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Camlin Fine Sciences Ltd's relative performance and valuation against major competitors.

Stock Name Tatva Chintan Pharma Chem Ltd ₹1449.10 (-5.42%) M. Cap (Cr) 33.90 1 Yr Return (%) +79.38% P/E (TTM) 191.12 PB Ratio 4.60

Stock Name Neogen Chemicals Ltd ₹1244.20 (-1.99%) M. Cap (Cr) 32.82 1 Yr Return (%) -35.68% P/E (TTM) 126.00 PB Ratio 4.16

Stock Name Vishnu Chemicals Ltd ₹480.85 (+0.74%) M. Cap (Cr) 32.37 1 Yr Return (%) +19.54% P/E (TTM) 23.38 PB Ratio 3.49

Stock Name Camlin Fine Sciences Ltd ₹154.07 (-3.25%) M. Cap (Cr) 28.96 1 Yr Return (%) +32.31% P/E (TTM) -99.17 PB Ratio 3.17

Stock Name NOCIL Ltd ₹169.90 (+0.49%) M. Cap (Cr) 28.38 1 Yr Return (%) -33.92% P/E (TTM) 44.99 PB Ratio 1.60

Stock Name Fineotex Chemical Ltd ₹24.62 (-1.72%) M. Cap (Cr) 28.21 1 Yr Return (%) -24.22% P/E (TTM) 28.67 PB Ratio 3.86

Stock Name Bhansali Engineering Polymers Ltd ₹92.40 (-0.41%) M. Cap (Cr) 22.99 1 Yr Return (%) -22.19% P/E (TTM) 13.80 PB Ratio 2.29

Camlin Fine Sciences Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Camlin Fine Sciences Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 21.86 Mar 2024 82.10 Mar 2023 18.52 Mar 2022 46.80 Mar 2021 26.02

PARTICULARS Investing Activities Mar 2025 -87.66 Mar 2024 -51.72 Mar 2023 -114.73 Mar 2022 -172.33 Mar 2021 -88.00

PARTICULARS Financing Activities Mar 2025 101.19 Mar 2024 -34.05 Mar 2023 78.39 Mar 2022 128.92 Mar 2021 80.05

PARTICULARS Net Cash Flow Mar 2025 35.39 Mar 2024 -3.67 Mar 2023 -17.82 Mar 2022 3.39 Mar 2021 18.08

Camlin Fine Sciences Ltd Shareholding Pattern

This shows the ownership breakdown of Camlin Fine Sciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 49.08%

Public 43.33%

Other Institutions 0.71%

FII 2.11%

Mutual Funds 4.77%

About Camlin Fine Sciences Ltd

Camlin Fine Sciences Limited was originally incorporated on November 30, 1993 as a Private Limited Company with the name of 'Camlicon Consultants Private Limited'. On June 1, 2006, the Company name was changed from Camlicon Consultants Private Limited to Camlin Fine Chemicals Private Limited. As per the Scheme of Arrangement, the Fine Chemicals Division of Camlin Limited got demerged and transferred to the Company effective from July 01, 2006. On August 11, 2006, the Company status was converted into Public Limited Company and the name was changed to Camlin Fine Chemicals Limited. W.e.f. 27th August, 2011 name of the Company was changed from Camlin Fine Chemicals Limited to Camlin Fine Sciences Limited.The Company is one of the India's leading manufacturers and exporters of Bulk Drugs, Fine Chemicals and Food Grade products. It manufactures active pharmaceutical ingredients (API's), food antioxidants and sweeteners. They operate in two business divisions, namely Food Ingredients Division and Industrial products Division. The company's products have applications in processed foods, edible oils, paints, polymers, alternative fuels (biodiesel), rubber, health, and pharmaceuticals.The company has a strong research and development which is focused on bringing in continual improvements on process and products, backward integration and developing innovative products. The research and development is equipped with comprehensive and updated instrumentation for conducting quality analysis, stability studies. The research and development also is equipped to conduct application studies on stability index of edible oils and Bio-diesel.In April 2006, the main object of the Company was altered to enable the Company to pursue business in Fine Chemicals. They launched a new product namely, Sucralose which is a synthetic sweetener with large demand and attractive price.The company entered into a joint venture with Viachem LLC USA on 51:49 basis and set up a company namely, Dulcette Technologies LLC for marketing Sucralose, Aspartame and Acesulfame-K and their blends in USA, Canada and Mexico. In March 30, 2007, the equity shares of the company were listed on the Bombay Stock Exchange (BSE).During the year 2007-08, the company increased the production capacity of Chemical & Chemical Products from 1,636 Ltrs/Kgs to 2,476 Ltrs/Kgs. The company acquired the control of Sangam Laboratories Ltd by acquiring 60% of the paid up equity share capital of the company. They invested Rs 5 lakh for controlling interest in the Equity Share Capital of Chemolutions Chemicals Ltd. In February 2008, the company entered into a joint venture agreement with Advanced Aerospace Technologies Inc., USA to manufacture and market speciality fine chemicals primarily to cater to European and U.S markets. During the year 2008-09, the company expanded the production capacity of Chemical & Chemical Products from 2,476 Ltrs/Kgs to 2,548 Ltrs/Kgs. The company invested Rs 25.50 lakh in Fine Lifestyle Brands Ltd and Rs.5.10 lakh in Fine Renewable Energy Ltd, which represents 51% of equity share capital of each of them. They further invested Rs 92.32 lakh in the share capital of their present subsidiaries, namely Sangam Laboratories Ltd, Chemolutions Chemicals Ltd and Dulcette Technologies LLC, USA.During the year 2009-10, the company expanded the production capacity of Chemical & Chemical Products from 2,458 Ltrs/Kgs to 3,500 Ltrs/Kgs. They are entering the field of Bio technology products and first patented, biotechnology based Natural shelf life enhancing formula for increasing shelf life of Natural farm produce, like fruits, vegetables and flowers.During the year 2011, Chemolutions Chemicals Limited, Fine Lifestyle Brands Limited and Fine Renewable Energy Limited ceased to be subsidiaries of the Company. The Hon'ble High Court Bombay, vide order dated 21st April, 2011 approved Scheme of Amalgamation for merger of Sangam Laboratories Limited, a 100% owned subsidiary with the Company. The establishment of two major business divisions, namely, Food and Industrial Products was completed. The Company expanded its manufacturing capacity of the food antioxidants, Ascorbyl Palmitate, TBHQ and BHA in 2012-13. In January 2016, it started operations in Central America with the launch of CFS Antioxidantes De Mexico, S.A. de C.V., a 100% subsidiary of Camlin Fine Sciences Ltd., acquired 65% stake in Dresen Qu�mica S.A.P.I de C.V, a leading food and feed blend company in Mexico; launched CFS North America, LLC, a 100% owned subsidiary of CFS for manufacturing and selling of customised antioxidant blends; launched Evanil, ethyl vanillin for food and bakery industry.On 15th April, 2016, a 100% wholly owned subsidiary CFS International Trading (Shanghai) Ltd. was incorporated in China (Shanghai) pilot free trade zone to manufacture and deal in speciality chemicals. On 22nd March, 2017, Chemolutions Chemicals Limited (CCL) allotted 62,67,003 equity shares on preferential basis to the Company. Post allotment, the shareholding of Company in CCL was 94.08% and CCL became the subsidiary of the Company. In July 2017, Company through its wholly owned stepdown subsidiary viz. CFS Europe S.p.A. acquired 51% stake in CFS Wanglong Flavours (Ningbo) Co. Ltd. erstwhile Ningbo Wanglong Flavors and Fragrances Company Limited. In April 2018, Company signed a joint venture contract with Pahang Pharma (S) Pte. Ltd., Singapore (Pahang) for incorporating a holding company, shareholding in the proportion of 51:49, named CFS Pahang Asia Pte. Ltd. in Singapore.In 2019, the Company reverse merged its wholly owned subsidiary in Mauritius viz., CFCL Mauritius Private Limited into CFS Europe Spa, Italy effective 25th June, 2019 and resultant to this merger, CFS Europe Spa became a wholly-owned subsidiary. The reverse merger of CFS Antioxidnates De Mexico De CV with Dresen Quimica SAPI De CV was effective 31st January, 2019 and resultant to reverse merger, CFS Antioxidantes De Mexico S.A. de. C.V. ceased to be the wholly-owned subsidiary of the Company from the aforementioned date. As a part of this initiative, Company acquired a company situated in Southern part of India, namely, AlgalR Nutrapharms Private Limited (AlgalR) which manufactures oils containing Omega 3 Fatty Acids. The company embarked upon its largest greenfield expansion in 2018 in Dahej, Gujarat for a green-technology-based DiPhenol plant for a 10,000 MT Di-Phenol facility. And in September 2020, it announced the commercial production of Hydroquinone and Catechol.During the financial year 2021-22, AlgalR NutraPharms Private Limited and CFS De Mexico Blends SAPI De CV became subsidiaries and Fine Lifestyle Brands Limited has ceased to be a Associate of the Company.The Company initiated the commercial production of Vanillin and Ethyl Vanillin in Dahej in January, 2023 in FY 2024.

Chairman & Managing Director

Ashish S Dandekar

Registered office Plot No F/11 & F/12 WICEL, Central Road Andheri(East), Mumbai, Maharashtra, 400093

FAX :91-22-67001000

Background

Incorporation Year 1993

Face Value ₹1.00

Market Lot 1

Camlin Fine Sciences Ltd Latest News

VIEW MORE NEWS

FAQs on Camlin Fine Sciences Ltd